chr6-10529336-A-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_145649.5(GCNT2):c.425A>T(p.Gln142Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000186 in 1,614,050 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 11/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_145649.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GCNT2 | NM_145649.5 | c.425A>T | p.Gln142Leu | missense_variant | 3/5 | ENST00000495262.7 | NP_663624.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GCNT2 | ENST00000495262.7 | c.425A>T | p.Gln142Leu | missense_variant | 3/5 | 2 | NM_145649.5 | ENSP00000419411 | P3 |
Frequencies
GnomAD3 genomes AF: 0.0000657 AC: 10AN: 152124Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000358 AC: 9AN: 251110Hom.: 0 AF XY: 0.0000221 AC XY: 3AN XY: 135702
GnomAD4 exome AF: 0.0000130 AC: 19AN: 1461808Hom.: 0 Cov.: 33 AF XY: 0.00000963 AC XY: 7AN XY: 727198
GnomAD4 genome AF: 0.0000723 AC: 11AN: 152242Hom.: 0 Cov.: 32 AF XY: 0.0000403 AC XY: 3AN XY: 74426
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 09, 2021 | The c.425A>T (p.Q142L) alteration is located in exon 3 (coding exon 1) of the GCNT2 gene. This alteration results from a A to T substitution at nucleotide position 425, causing the glutamine (Q) at amino acid position 142 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at